...
首页> 外文期刊>British Journal of Cancer >Renal and haemopoietic proliferative defects as a delayed consequence of cis-platin, adriamycin and daunomycin treatments
【24h】

Renal and haemopoietic proliferative defects as a delayed consequence of cis-platin, adriamycin and daunomycin treatments

机译:顺铂,阿霉素和道诺霉素治疗的延迟结果导致肾脏和造血细胞增殖缺陷

获取原文
           

摘要

The long-term effects of Adriamycin (ADR), daunomycin (DMN) and cis-dichlorodiammine platinum (II) (DDP) on the ability of murine renal tubular epithelium and erythropoiesis to respond to an acute proliferative stress was investigated. Folic acid (FA) and acute anaemia induced by bleeding were used as acute proliferative stimuli for renal-tubule epithelium and erythropoiesis respectively. The ability of these normal cell-renewal systems to mount a regenerative proliferative response was evaluated by radioisotopic, morphological and gravimetric techniques 4 months after drug treatment. The results indicate that pretreatment with these agents produce a long-lasting reduction in the ability of these cell-renewal systems to mount regenerative proliferation. In the kidney, the ability to respond to FA was most severely compromised by ADR and DDP, whereas in the erythropoietic system all 3 agents induced a long-lasting proliferative defect.
机译:研究了阿霉素(ADR),道诺霉素(DMN)和顺式二氯二氨铂(II)(DDP)对鼠肾小管上皮和红细胞生成对急性增生应激反应能力的长期影响。叶酸(FA)和出血引起的急性贫血分别用作肾小管上皮和红细胞生成的急性增殖刺激。药物治疗4个月后,通过放射性同位素,形态学和重量分析技术评估了这些正常细胞更新系统产生再生增殖反应的能力。结果表明,用这些试剂进行预处理会使这些细胞更新系统促进再生增殖的能力长期持续降低。在肾脏中,对FA的反应能力受到ADR和DDP的最严重损害,而在促红细胞生成系统中,所有3种药物均会引起持久的增殖缺陷。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号